ZA982246B - Method of treating chronic progressive vascular scarring diseases - Google Patents

Method of treating chronic progressive vascular scarring diseases

Info

Publication number
ZA982246B
ZA982246B ZA982246A ZA982246A ZA982246B ZA 982246 B ZA982246 B ZA 982246B ZA 982246 A ZA982246 A ZA 982246A ZA 982246 A ZA982246 A ZA 982246A ZA 982246 B ZA982246 B ZA 982246B
Authority
ZA
South Africa
Prior art keywords
treating chronic
chronic progressive
progressive vascular
vascular scarring
scarring diseases
Prior art date
Application number
ZA982246A
Other languages
English (en)
Inventor
Gary E Striker
Liliane J Striker
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25283204&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA982246(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Us Health filed Critical Us Health
Publication of ZA982246B publication Critical patent/ZA982246B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA982246A 1997-04-16 1998-03-17 Method of treating chronic progressive vascular scarring diseases ZA982246B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/840,777 US20010005720A1 (en) 1995-06-07 1997-04-16 Method of treating chronic progressive vascular scarring diseases

Publications (1)

Publication Number Publication Date
ZA982246B true ZA982246B (en) 1998-09-17

Family

ID=25283204

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA982246A ZA982246B (en) 1997-04-16 1998-03-17 Method of treating chronic progressive vascular scarring diseases

Country Status (17)

Country Link
US (1) US20010005720A1 (xx)
EP (1) EP0986392A4 (xx)
JP (1) JPH1149802A (xx)
KR (1) KR20010006511A (xx)
CN (1) CN1259871A (xx)
AR (1) AR008559A1 (xx)
AU (1) AU750182B2 (xx)
BR (1) BR9809396A (xx)
CA (1) CA2285950A1 (xx)
HU (1) HUP0003256A3 (xx)
IL (1) IL132389A0 (xx)
NO (1) NO995024L (xx)
NZ (1) NZ500527A (xx)
SK (1) SK142599A3 (xx)
TW (1) TW557213B (xx)
WO (1) WO1998046237A1 (xx)
ZA (1) ZA982246B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005292202A1 (en) * 2004-10-01 2006-04-13 Keryx Biopharmaceuticals, Inc. Methods using glycosaminoglycans for the treatment of kidney disease
WO2010103837A1 (ja) 2009-03-11 2010-09-16 ゼライス株式会社 アテローム性動脈硬化症の進行抑制薬・予防薬・血中コレステロール低下薬・機能性食品・特定保健用食品
CN102327282A (zh) * 2010-09-01 2012-01-25 吴洪 戊糖多聚硫酸酯用于制备治疗糖尿病肾病的药物中的用途
KR102559743B1 (ko) 2016-08-31 2023-07-25 오지 홀딩스 가부시키가이샤 산성 자일로올리고당의 제조 방법 및 산성 자일로올리고당
JP6225321B1 (ja) 2016-08-31 2017-11-08 王子ホールディングス株式会社 ポリ硫酸ペントサンの製造方法
JP6281659B1 (ja) 2017-02-28 2018-02-21 王子ホールディングス株式会社 ポリ硫酸ペントサン、医薬組成物及び抗凝固剤
WO2018221547A1 (ja) 2017-05-31 2018-12-06 王子ホールディングス株式会社 保湿外用剤
WO2019054344A1 (ja) 2017-09-12 2019-03-21 王子ホールディングス株式会社 ポリ硫酸ペントサン及びポリ硫酸ペントサンの製造方法
HUE062342T2 (hu) 2017-12-20 2023-10-28 Oji Holdings Corp Pentozán-poliszulfát, valamint pentozán-poliszulfátot tartalmazó gyógyszerek
WO2023070164A1 (en) * 2021-10-28 2023-05-04 Paradigm Biopharmaceuticals Ltd Treatment of heart failure with preserved ejection fraction

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820693A (en) * 1986-05-22 1989-04-11 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US5643892A (en) * 1995-06-07 1997-07-01 Baker Norton Pharmaceuticals, Inc. Method of treating chronic progressive vascular diseases

Also Published As

Publication number Publication date
AR008559A1 (es) 2000-01-19
AU7248298A (en) 1998-11-11
KR20010006511A (ko) 2001-01-26
NO995024L (no) 1999-12-13
TW557213B (en) 2003-10-11
CN1259871A (zh) 2000-07-12
HUP0003256A3 (en) 2001-12-28
IL132389A0 (en) 2001-03-19
US20010005720A1 (en) 2001-06-28
JPH1149802A (ja) 1999-02-23
BR9809396A (pt) 2000-06-13
CA2285950A1 (en) 1998-10-22
NZ500527A (en) 2001-10-26
SK142599A3 (en) 2001-12-03
NO995024D0 (no) 1999-10-15
HUP0003256A2 (hu) 2001-02-28
WO1998046237A1 (en) 1998-10-22
AU750182B2 (en) 2002-07-11
EP0986392A1 (en) 2000-03-22
EP0986392A4 (en) 2000-04-26

Similar Documents

Publication Publication Date Title
HUP0001237A3 (en) Methods for treating vascular disorders
AU9028798A (en) Method of improving drug treatment
HU9904434D0 (en) Method of treating nitrate-induced tolerance
ZA977564B (en) Method of treatment
ZA982246B (en) Method of treating chronic progressive vascular scarring diseases
GB9715295D0 (en) Novel method of treatment
EP1007046A4 (en) METHOD FOR TREATING CHRONIC BRONCHITIS
ZA964247B (en) Method of treating chronic progressive vascular diseases
AU6151899A (en) Methods of treating chronic pain
EP0933803A4 (en) PLASMA TREATMENT METHOD
GB9712866D0 (en) Novel method of treatment
GB9707693D0 (en) Novel method of treatment
GB9715298D0 (en) Novel method of treatment
GB9715306D0 (en) Novel method of treatment
GB9618341D0 (en) Method of treatment
ZA973988B (en) Method of treatment
GB9407335D0 (en) Method of treatment
PL313573A1 (en) Method of enhancing a healing process of some chronic diseases
GB9724289D0 (en) Method of treatment
GB9717399D0 (en) Method of treatment
EG24157A (en) Novel method of treatment
EG24199A (en) Novel method of treatment
GB9701448D0 (en) Methods of treatment
PL309497A1 (en) Agent for treating chronic skin diseases
GB9712865D0 (en) Novel method of treatment